News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
658,715 Results
Type
Article (47449)
Company Profile (354)
Press Release (610894)
Multimedia
Podcasts (134)
Webinars (23)
Section
Business (178144)
Career Advice (2603)
Deals (32386)
Drug Delivery (139)
Drug Development (80785)
Employer Resources (153)
FDA (15530)
Job Trends (13632)
News (312995)
Policy (30666)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2784)
Academic (1)
Accelerated approval (45)
Adcomms (33)
Allergies (172)
Alliances (44833)
ALS (210)
Alzheimer's disease (1859)
Antibody-drug conjugate (ADC) (463)
Approvals (15833)
Artificial intelligence (659)
Autoimmune disease (265)
Automation (47)
Bankruptcy (338)
Best Places to Work (11023)
BIOSECURE Act (18)
Biosimilars (210)
Biotechnology (262)
Bladder cancer (187)
Brain cancer (73)
Breast cancer (731)
Cancer (5774)
Cardiovascular disease (488)
Career advice (2219)
Career pathing (44)
CAR-T (336)
CDC (58)
Celiac Disease (1)
Cell therapy (903)
Cervical cancer (41)
Clinical research (69696)
Collaboration (2052)
Company closure (5)
Compensation (997)
Complete response letters (95)
COVID-19 (2788)
CRISPR (113)
C-suite (1119)
Cystic fibrosis (156)
Data (7578)
Decentralized trials (3)
Denatured (32)
Depression (173)
Dermatology (72)
Diabetes (580)
Diagnostics (6566)
Digital health (48)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (329)
Drug pricing (209)
Drug shortages (36)
Duchenne muscular dystrophy (289)
Earnings (71864)
Editorial (71)
Employer branding (21)
Employer resources (143)
Events (100816)
Executive appointments (1109)
FDA (19113)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1678)
Gene editing (244)
Generative AI (60)
Gene therapy (746)
GLP-1 (1121)
Government (4831)
Grass and pollen (8)
Guidances (402)
Healthcare (18086)
HIV (81)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (318)
Immuno-oncology (93)
Indications (170)
Infectious disease (3130)
Inflammatory bowel disease (223)
Inflation Reduction Act (16)
Influenza (135)
Intellectual property (282)
Interviews (541)
IPO (15130)
IRA (56)
Job creations (2946)
Job search strategy (1789)
JPM (69)
Kidney cancer (20)
Labor market (76)
Layoffs (577)
Leadership (46)
Legal (6783)
Liver cancer (105)
Longevity (27)
Lung cancer (783)
Lymphoma (420)
Machine learning (57)
Management (53)
Manufacturing (961)
MASH (196)
Medical device (12371)
Medtech (12448)
Mergers & acquisitions (18434)
Metabolic disorders (1538)
mRNA (213)
Multiple sclerosis (186)
NASH (24)
Neurodegenerative disease (425)
Neuropsychiatric disorders (116)
Neuroscience (3391)
Neurotech (1)
NextGen: Class of 2026 (6248)
Non-profit (4302)
Now hiring (71)
Obesity (731)
Opinion (340)
Ovarian cancer (210)
Pain (251)
Pancreatic cancer (289)
Parkinson's disease (369)
Partnered (34)
Patents (576)
Patient recruitment (644)
Peanut (64)
People (58183)
Pharmaceutical (55)
Pharmacy benefit managers (28)
Phase 1 (21830)
Phase 2 (30733)
Phase 3 (22909)
Pipeline (7800)
Policy (332)
Postmarket research (2488)
Preclinical (9308)
Press Release (64)
Prostate cancer (292)
Psychedelics (62)
Radiopharmaceuticals (334)
Rare diseases (1106)
Real estate (4837)
Recruiting (67)
Regulatory (24348)
Reports (34)
Research institute (2435)
Resumes & cover letters (384)
Rett syndrome (37)
RNA editing (26)
RSV (88)
Schizophrenia (184)
Series A (286)
Series B (214)
Service/supplier (4)
Sickle cell disease (119)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (45)
Startups (3363)
State (2)
Stomach cancer (20)
Supply chain (119)
Tariffs (84)
The Weekly (100)
Vaccines (1104)
Venture capital (111)
Weight loss (496)
Women's health (104)
Worklife (21)
Date
Today (190)
Last 7 days (698)
Last 30 days (2744)
Last 365 days (29966)
2026 (9961)
2025 (29785)
2024 (34499)
2023 (38548)
2022 (49558)
2021 (53521)
2020 (51786)
2019 (44221)
2018 (33367)
2017 (31014)
2016 (29715)
2015 (34763)
2014 (27001)
2013 (22092)
2012 (23421)
2011 (24303)
2010 (21997)
Location
Africa (812)
Alabama (93)
Alaska (4)
Arizona (281)
Arkansas (14)
Asia (40977)
Australia (7779)
California (11978)
Canada (3569)
China (1343)
Colorado (514)
Connecticut (502)
Delaware (387)
Europe (90421)
Florida (1826)
Georgia (385)
Hawaii (3)
Idaho (61)
Illinois (962)
India (92)
Indiana (559)
Iowa (19)
Japan (517)
Kansas (123)
Kentucky (44)
Louisiana (39)
Maine (66)
Maryland (1493)
Massachusetts (8815)
Michigan (329)
Minnesota (646)
Mississippi (6)
Missouri (143)
Montana (35)
Nebraska (25)
Nevada (132)
New Hampshire (88)
New Jersey (3316)
New Mexico (28)
New York (3168)
North Carolina (1573)
North Dakota (8)
Northern California (5859)
Ohio (346)
Oklahoma (20)
Oregon (41)
Pennsylvania (2399)
Puerto Rico (27)
Rhode Island (46)
South America (1110)
South Carolina (82)
South Dakota (2)
Southern California (4819)
Tennessee (185)
Texas (1944)
United States (42978)
Utah (368)
Vermont (1)
Virginia (294)
Washington D.C. (71)
Washington State (990)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
658,715 Results for "prescient therapeutics formerly known as virax holdings limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
March 31, 2026
·
5 min read
Press Releases
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
November 4, 2025
·
5 min read
Press Releases
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
August 27, 2025
·
5 min read
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 30, 2026
·
19 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
December 10, 2025
·
6 min read
Business
Prescient Healthcare Group Appoints Two New Members to its Board of Directors
Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient’s global mission.
April 19, 2024
·
3 min read
1 of 65,872
Next
